A multicenter, randomized, open-label, pharmacokinetics and safety study of pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux disease. [electronic resource]
Producer: 20110906Description: 876-87 p. digitalISSN:- 1552-4604
- 2-Pyridinylmethylsulfinylbenzimidazoles -- administration & dosage
- Adolescent
- Child
- Delayed-Action Preparations -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Gastroesophageal Reflux -- blood
- Genotype
- Humans
- Inactivation, Metabolic -- genetics
- Male
- Pantoprazole
- Proton Pump Inhibitors -- administration & dosage
- Tablets -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.